Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 66,636 shares at $2.57 ($170K) on 2013-10-02, disclosed to the SEC on 2013-10-03.
Scheduled sale ($170k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.61 | 27,736 | $72K | 42.7% |
| 2 | $2.57 | 13,200 | $34K | 20.0% |
| 3 | $2.46 | 25,700 | $63K | 37.3% |
| Total | $2.54 avg | 66,636 | $170K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |